Maria Arantxa Horga
New York City Metropolitan Area
774 followers
500 connections
New York City Metropolitan Area
774 followers
500 connections
About
Pharmaceutical executive with broad expertise in clinical development in Biotech and…
Activity
-
Welcome Sylke Poehling, PhD, Spark’s new Chief Executive Officer. Sylke brings a wealth of experience in drug development and genomic medicine and…
Welcome Sylke Poehling, PhD, Spark’s new Chief Executive Officer. Sylke brings a wealth of experience in drug development and genomic medicine and…
Liked by Maria Arantxa Horga
-
Pleasure to host Brad Loncar at Versant and our vibrant Ridgeline Discovery Engine and featuring our portfolio company Six Peaks Bio.
Pleasure to host Brad Loncar at Versant and our vibrant Ridgeline Discovery Engine and featuring our portfolio company Six Peaks Bio.
Liked by Maria Arantxa Horga
-
I'm honored to step into this role and look forward to working alongside the incredible #teamSpark to unlock the transformative power of gene…
I'm honored to step into this role and look forward to working alongside the incredible #teamSpark to unlock the transformative power of gene…
Liked by Maria Arantxa Horga
Experience
Languages
-
Spanish, Italian, English
-
More activity by Maria Arantxa
-
Excited to attend the Nordic Life Science Days. External innovation is a key pillar in Roche, working together we can discover and develop truly…
Excited to attend the Nordic Life Science Days. External innovation is a key pillar in Roche, working together we can discover and develop truly…
Liked by Maria Arantxa Horga
-
Today, we are excited to announce positive initial data from the Phase 2 study evaluating bemnifosbuvir, our oral nucleotide polymerase inhibitor in…
Today, we are excited to announce positive initial data from the Phase 2 study evaluating bemnifosbuvir, our oral nucleotide polymerase inhibitor in…
Liked by Maria Arantxa Horga
-
Today Bluejay Therapeutics announced positive preliminary data from the Phase 2 study of BJT-778 in patients with chronic #hepatitis D. The data…
Today Bluejay Therapeutics announced positive preliminary data from the Phase 2 study of BJT-778 in patients with chronic #hepatitis D. The data…
Liked by Maria Arantxa Horga
-
We continue to advocate for adults 65 and immunocompromised patients who are at the greatest risk of #COVID19 disease progression, hospitalization…
We continue to advocate for adults 65 and immunocompromised patients who are at the greatest risk of #COVID19 disease progression, hospitalization…
Liked by Maria Arantxa Horga
-
Hear from former Surgeon General, Jerome Adams, as he explains why we must prioritize new oral antiviral treatments and protect seniors and…
Hear from former Surgeon General, Jerome Adams, as he explains why we must prioritize new oral antiviral treatments and protect seniors and…
Liked by Maria Arantxa Horga
-
Just in time for Sunday!! 🏈 Honored to be featured alongside my former colleague and UK counterpart Ben Andrews!
Just in time for Sunday!! 🏈 Honored to be featured alongside my former colleague and UK counterpart Ben Andrews!
Liked by Maria Arantxa Horga
-
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral…
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral…
Liked by Maria Arantxa Horga
-
Love this. Thank you #Nike. Get crazy my fellow females - you can do it. #inspriation #possibilities #womenleaders
Love this. Thank you #Nike. Get crazy my fellow females - you can do it. #inspriation #possibilities #womenleaders
Liked by Maria Arantxa Horga
-
Scientists have worked to develop RSV vaccines for more than 50 years without success. But now we’re on the verge of a scientific breakthrough that…
Scientists have worked to develop RSV vaccines for more than 50 years without success. But now we’re on the verge of a scientific breakthrough that…
Liked by Maria Arantxa Horga
-
New paper from the lab (published online the same day the first author, Fares Al-Mansour, passed his viva). We discovered a new, very potent…
New paper from the lab (published online the same day the first author, Fares Al-Mansour, passed his viva). We discovered a new, very potent…
Liked by Maria Arantxa Horga
-
On Tuesday, the FDA accepted Pfizer's submission for an investigational maternal respiratory syncytial virus (RSV) vaccine candidate for Priority…
On Tuesday, the FDA accepted Pfizer's submission for an investigational maternal respiratory syncytial virus (RSV) vaccine candidate for Priority…
Liked by Maria Arantxa Horga
-
🎓 Salvador Macip, nuevo director de los Estudios de Ciencias de la Salud de la UOC. 🏥 Actualmente, es catedrático de la UOC y profesor de la…
🎓 Salvador Macip, nuevo director de los Estudios de Ciencias de la Salud de la UOC. 🏥 Actualmente, es catedrático de la UOC y profesor de la…
Liked by Maria Arantxa Horga
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More